Metal-on-Metal Hip Implant Lawsuit 2026: the $4 Billion Settlement, Revision Risks & Who Can Still File

If you received a metal-on-metal hip implant — most notably the DePuy ASR, recalled in 2010 — you may still have a legal claim. Johnson & Johnson paid more than $4 billion through a settlement program covering over 8,000 revision-surgery patients, and lawsuits for other metal-on-metal devices continue today.

Key Facts

  • On August 24, 2010, the FDA announced DePuy's voluntary recall of the ASR hip system — roughly 93,000 implants worldwide, about 37,000 of them in the United States — after the UK joint registry found a 13% revision rate.
  • In late 2013, Johnson & Johnson launched a settlement program worth more than $4 billion for patients who had revision surgery, with documented base payments of $150,000 to $250,000 depending on the patient's age, weight, smoking history, and how long the implant had been in place.
  • In December 2016, a Dallas jury awarded $1.04 billion to six DePuy Pinnacle plaintiffs (reduced to $500 million by the judge in January 2017).
  • In November 2014, Stryker agreed to pay more than $1.4 billion to resolve over 4,000 lawsuits over its recalled Rejuvenate and ABG II hip systems.

What "Metal-on-Metal" Actually Means

A metal-on-metal hip implant is an artificial hip joint in which both the ball and the socket are made of metal alloys. The design was meant to be more durable for younger, active patients — but the metal surfaces rub against each other with every step, and that friction was the beginning of the trouble.

The central injury alleged in these cases is metallosis, which is the buildup of microscopic metal debris in the tissue around the implant. Over time, that debris can inflame and kill surrounding muscle and bone, loosen the device, and send elevated levels of cobalt and chromium into the bloodstream. Many patients developed pseudotumors — a pseudotumor is a mass of inflamed tissue that forms around a failing implant — long before they realized anything was wrong.

Which Implants Are Named in Lawsuits

Three product lines dominate the litigation. The DePuy ASR — made by Johnson & Johnson's DePuy unit — is the recalled flagship of this litigation, the subject of MDL 2197. MDL stands for multidistrict litigation, which is the federal procedure that consolidates similar lawsuits before one judge for pretrial proceedings. The DePuy Pinnacle, a related device with a metal-on-metal version that was never recalled, generated its own federal consolidation, MDL 2244, and the largest jury verdicts in the field. The third is Stryker's Rejuvenate and ABG II, recalled in July 2012 after reports of fretting and corrosion at the modular neck junction, which settled for over $1.4 billion.

A word of honesty: the implants named above are the ones with documented recalls, verdicts, or settlements. If you carry a different metal-on-metal device, it does not mean you have no claim — but it does mean your case will be evaluated on its own facts, and you should confirm your exact model from your operative report rather than assuming.

The Warning Signs Patients Report

The symptoms that most often precede a metal-on-metal failure read like a slow-motion accident: groin or thigh pain that worsens months or years after surgery, swelling around the joint, a clicking or grinding sensation, a feeling that the hip is unstable or "giving way," and in some patients, fatigue or systemic symptoms consistent with metal-ion exposure. Revision surgery — which is a second operation to remove the failed implant and install a replacement — is itself riskier than the original procedure, with a longer recovery and greater complication rates.

Compensation varies widely by case, and most settlements are confidential. That is precisely why documented programs matter: they give you a floor of what manufacturers have actually paid rather than a rumor of what cases "might" be worth.

The $4 Billion Settlement Program, Explained

Announced in late 2013, the DePuy ASR settlement program is one of the largest product-liability resolutions in history. It covered patients whose ASR implants had been removed or revised, with base payments of $150,000 to $250,000 and additional compensation for extraordinary injuries. Brown Greer, an independent claims administrator, processed the claims, and in May 2014 DePuy confirmed it would proceed with the program after participation thresholds were met. A later extension round brought patients revised after March 2015 into coverage, at a reported cost of around $420 million more.

Settlement programs are not lawsuits you join by shouting into a crowd. They are negotiated claims processes with medical-documentation requirements, filing windows, and strict eligibility rules — which is why attorneys screen cases so carefully before submitting them. If you want to understand how device cases compare to drug cases, see our guide to the IVC filter lawsuits, where a similar device-injury program played out with thousands of claimants.

The Big Verdicts That Followed

Not every case settled. The Pinnacle bellwethers — a bellwether is a representative case tried early so both sides can gauge how juries respond — produced some of the largest device verdicts ever reported. In March 2016, five plaintiffs won $502 million (later reduced to $150 million); in December 2016, six plaintiffs won $1.04 billion (reduced to $500 million in January 2017, with the judge citing constitutional limits on punitive damages). These were named-case verdicts, not averages, and reductions on appeal are common. Still, they set the tone for every negotiation that followed — including, in a different device field, the $40 million verdict in the Bard PowerPort litigation.

Who Can Still File in 2026

The practical question is not whether the litigation happened — it did, and it paid — but whether your clock is still running. Every state has a statute of limitations, which is the deadline for filing a lawsuit, and many states apply a "discovery rule" that starts the clock when you first knew, or reasonably should have known, that the implant caused your injury. Patients who had revision surgery years ago may be time-barred; patients who only recently learned their implant was metal-on-metal, or who are experiencing new symptoms, may not be.

The strongest candidates today are patients with a documented metal-on-metal device who have had, or are scheduled for, revision surgery; patients with blood work showing elevated cobalt or chromium tied to the implant; and patients with imaging showing pseudotumor or tissue damage. As with the Paragard IUD litigation, device identity — the exact model in your medical records — is the first and most decisive fact.

How to Check Your Claim, Step by Step

First, get your operative report and implant card from your surgeon's office or hospital records; you need the manufacturer and model name in writing. Second, gather blood tests (metal-ion levels), imaging, and the revision-surgery records if you have had one. Third, write a plain timeline: implant date, when symptoms began, every doctor visit about the hip, every diagnosis. Fourth, have an attorney who handles device litigation review the file — these cases are almost always taken on contingency, meaning the firm is paid only if the claim succeeds.

For plain-English explainers on lawsuits and money topics, watch Problem Solved on YouTube.

Who Benefits From This — and Who Does Not

Who benefits most from this guide:

Patients with a DePuy ASR implant who had revision surgery. How: the ASR settlement program covered patients whose ASR implants had been removed or revised, with base payments of $150,000 to $250,000 and additional compensation for extraordinary injuries.

Patients with blood work showing elevated cobalt or chromium, or imaging showing a pseudotumor or tissue damage. How: this article lists those records as the profile of the strongest candidates today.

Patients who only recently learned their implant was metal-on-metal, or who are experiencing new symptoms. How: many states apply a discovery rule that starts the clock when you first knew, or reasonably should have known, that the implant caused your injury, so an attorney can calculate whether your window is still open.

Who does not benefit:

Patients whose revision surgery was years ago and whose deadline has already passed. How: patients who had revision surgery years ago may be time-barred, because every state sets its own filing deadline.

Anyone carrying a different metal-on-metal device but holding no records of the exact model. How: a case for another device is evaluated on its own facts, and device identity from the operative report is the first and most decisive fact.

Anyone expecting a Pinnacle verdict figure as an average payout. How: the $502 million and $1.04 billion Pinnacle figures were named-case verdicts, later reduced on appeal, not averages for ordinary claims.

A similar device-injury program, with thousands of claimants, is covered in our guide to the IVC filter lawsuits, where the same documentation discipline decides which claims move forward.

Frequently Asked Questions

Can I still file a DePuy ASR lawsuit in 2026?

Possibly, if your state's deadline has not passed — many states start the clock under the discovery rule when you learned the implant caused your injury. An attorney can calculate your exact window from your medical records.

How much was the DePuy ASR settlement?

The program announced in late 2013 was worth more than $4 billion in total, with documented base payments of $150,000 to $250,000 per qualifying patient; extraordinary injuries could qualify for more.

What is metallosis from a hip implant?

Metallosis is the accumulation of microscopic metal debris shed by a metal-on-metal joint. It can destroy surrounding tissue, loosen the implant, and raise cobalt and chromium levels in the blood.

Is the DePuy Pinnacle hip part of the lawsuits?

Yes. The metal-on-metal version of the DePuy Pinnacle generated MDL 2244 and produced the field's largest reported verdicts, including $1.04 billion for six plaintiffs in December 2016 (reduced to $500 million).

Who benefits most from a metal-on-metal hip implant claim?

Patients with a documented metal-on-metal device who had, or are scheduled for, revision surgery benefit most, especially with blood work showing elevated cobalt or chromium or imaging showing a pseudotumor or tissue damage. The ASR program paid base amounts of $150,000 to $250,000 to qualifying revised patients, with more for extraordinary injuries.

How do I start a hip implant claim?

Get your operative report and implant card showing the manufacturer and model, gather blood tests for metal-ion levels, imaging, and any revision-surgery records, write a plain timeline of implant date, symptoms, and doctor visits, and have a device-litigation attorney review the file, since these cases are almost always taken on contingency.

Disclaimer: This article is general information, not legal or medical advice. Device claims have strict deadlines that vary by state; speak with a licensed attorney about your situation before relying on any of it.

Watch on YouTube

Problem Solved on YouTube